Total neoadjuvant therapy for locally advanced rectal cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effectiveness and safety of total neoadjuvant therapy versus standard therapy in individuals with locally advanced rectal cancer.

This is a protocol.

Published:

14 May 2025

Authors:

Mueller S, Kao Y-S, Kastner C, Chen P-H, Hendricks A, Lee GY, Koehler F, Jhou H-J, Germer C-T, Kang E-NY, Janka H, Ho C-L, Lee C-H, Wiegering A

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Mueller S, Kao Y-S, Kastner C, Chen P-H, Hendricks A, Lee GY, Koehler F, Jhou H-J, Germer C-T, Kang E-NY, Janka H, Ho C-L, Lee C-H, Wiegering A. Total neoadjuvant therapy for locally advanced rectal cancer (Protocol). Cochrane Database of Systematic Reviews 2025, Issue 5. Art. No.: CD015590. DOI: 10.1002/14651858.CD015590.